Why location changes the risk — and the treatment plan — for squamous cell carcinoma
Bring a printable list of questions to your appointment, or share this page with someone who needs it.
Not all squamous cell carcinoma (SCC) carries the same risk. Where a tumor sits on the body changes how it behaves — some locations have thinner skin over cartilage or bone, richer lymphatic drainage, or anatomy that makes a growing lesion easy to overlook or mistake for something harmless. SCC on the ear, lip, scalp, temple, around the eyes, on the fingers or under a nail, or in the genital area is treated by dermatologists as inherently higher-risk than an identical-looking SCC on the forearm or back.
This matters for how quickly you should act. A persistent lesion in one of these locations deserves a prompt biopsy, not a "let's watch it" approach — and if you're diagnosed with SCC at one of these sites, understanding why it's being handled differently can help the recommendations make more sense.
A few anatomic features, often overlapping, explain why the same cancer behaves more aggressively at certain sites:
National guidelines formally classify SCC on the "mask area" of the face — central face, eyelids, eyebrows, nose, lips, chin, ear, and temple — along with the scalp, hands, feet, nail unit, and genitalia, as higher-risk locations regardless of the tumor's size, which changes both the recommended margin and how closely you're followed afterward.
SCC on the external ear has one of the higher metastasis rates of any cutaneous SCC location. In a series of 170 ear SCC cases treated with Mohs surgery, 10.6% of patients developed lymph node metastasis despite complete tumor removal. Because the ear's cartilage framework is thin and the skin over it doesn't leave much margin, ear SCC is almost always referred to a Mohs surgeon, frequently followed by a reconstructive procedure to restore the ear's shape.
SCC on the lip — especially the lower lip, which takes the brunt of a lifetime of sun exposure — carries a meaningfully higher risk of lymph node spread than SCC on the surrounding facial skin. Tumors that cross the vermilion border (the line between lip and normal skin) raise the stakes for reconstruction, since surgery has to balance removing the cancer completely against preserving the ability to speak, eat, and form a normal-looking mouth. This combination of higher metastatic risk and reconstructive difficulty is why lip SCC is generally treated by, or in consultation with, a Mohs surgeon or head-and-neck specialist.
Like the ear, the scalp and temple sit close to bone with limited soft tissue in between, and the temple region carries an added risk because of its proximity to facial nerve branches. Skin around the eyes (periorbital skin) adds another layer of complexity: margins have to be planned carefully to avoid compromising eyelid function or tear drainage, which is why these tumors are also typically handled with Mohs surgery and oculoplastic or reconstructive input.
Periungual and subungual SCC — arising around or beneath the nail, most often on the thumb or index finger — is one of the most commonly delayed SCC diagnoses because it looks so much like a wart, chronic paronychia (nail-fold infection), or fungal nail disease. It's frequently associated with HPV infection rather than sun exposure alone. Because diagnosis is so often delayed, treatment can require removing part or all of the nail unit, and in advanced cases, amputation of the distal fingertip to fully clear the tumor — an outcome that earlier biopsy of a persistent nail change could often prevent.
SCC in the genital or perianal area has a different underlying biology than most sun-exposed skin SCC — it's frequently driven by high-risk HPV strains, similar to cervical or anal cancer, rather than by cumulative UV exposure. It's staged and treated differently, and typically needs referral to a specialist team (dermatology working alongside colorectal, gynecologic, or urologic oncology) rather than management in a routine skin-cancer visit.
Across all of these sites, the pattern is the same: higher-risk anatomy plus a higher chance of delayed diagnosis. Our SCC treatment options guide covers Mohs surgery and the other approaches in more depth, and our guide to recurrence and metastasis risk explains how location factors into your overall risk category alongside tumor size, depth, and other features.
A persistent scaly patch, sore, or growth on the ear, lip, scalp, near the eye, under a nail, or in the genital area that doesn't heal within a few weeks warrants a biopsy — not a period of watching to see if it goes away. Because these sites are both higher-risk biologically and more prone to delayed diagnosis, prompt evaluation is the single biggest factor in keeping treatment straightforward instead of extensive.
Location is one of the most important pieces of information your dermatologist uses to decide how aggressively to treat and monitor an SCC. Thin skin over cartilage, proximity to major lymphatic pathways, and a tendency toward delayed diagnosis all combine to make the ear, lip, scalp, periorbital skin, fingers and nail unit, and genital skin sites that deserve extra vigilance.
If you notice a persistent, non-healing change at any of these sites, the right move is a prompt evaluation and biopsy — catching SCC early at a high-risk location is what keeps a straightforward outpatient procedure from becoming a much bigger undertaking.
Disclaimer: This article is for educational purposes only and not a substitute for professional medical advice. Always consult a qualified dermatologist about a persistent skin change, especially at a high-risk location.
Chat with our AI guide for personalized information about SCC in high-risk locations
Chat with the Navigator